SHIFT: Studying HIV Immunology After Fecal Transplant

NCT03163784 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped The study closed because of shifting research priorities and interests.

Conditions

HIV/AIDS
Dysbiosis
Inflammation

Interventions

BIOLOGICAL: Fecal Inoculum Capsule
BIOLOGICAL: Placebo (for Fecal Inoculum Capsule)
DRUG: Antibiotic
DRUG: Antibiotic Placebo

Sponsor

Massachusetts General Hospital